Navigation Links
Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
Date:4/24/2008

current standard of care, and patients with non-alcoholic fatty liver disease (NAFLD), there are currently no therapeutic options available to prevent progression to cirrhosis, liver failure and liver cancer," stated Dr. Gane. "In the future, these patients may benefit from maintenance therapy with interventions such as MitoQ, which block either hepatic necroinflammation or fibrogenesis."

"In the coming year, Antipodean plans to explore and develop its lead compound for the treatment of hepatological diseases, particularly non- alcoholic fatty liver disease (NAFLD)," said Ken Taylor, Ph.D., Chief Executive Officer of Antipodean Pharmaceuticals. "The Company is actively seeking to achieve this goal with the help of a pharmaceutical partner."

A 12-month study in patients in Parkinson's disease showed MitoQ to be well tolerated; however, there was no significant effect on disease progression. Dr. Barry Snow, Department of Neurology, Auckland Hospital, New Zealand and Principal Investigator of the trial of MitoQ in Parkinson's disease, believes that the lack of efficacy in Parkinson's Disease may have been due to the large number of impaired cells in that disease; these cells may have had limited or no ability to regenerate, and thus could not benefit from MitoQ's antioxidant properties. The Company believes MitoQ has therapeutic potential in diseases where cell regeneration occurs, such as hepatological and dermatological disorders.

About MitoQ(R)

MitoQ(R) is a mitochondria-targeted antioxidant that selectively blocks mitochondrial oxidative damage and prevents liver cell apoptosis. MitoQ is based on a novel technology, targeted lipophilic cations that transport and concentrate antioxidants into the mitochondria-organelles inside cells that provide energy for life processes-where they accumulate up to a thousand fold. Targeted antioxidants can reduce the hepatic oxidative damage that is induced by viral infection and that is also involved in
'/>"/>

SOURCE Antipodean Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
2. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
3. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
4. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
5. Amylin Pharmaceuticals Reports First Quarter Financial Results
6. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
7. Access Pharmaceuticals Announces New Data on Angiolix(R)
8. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
9. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
10. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
11. Alexion Pharmaceuticals Invites You to Participate in its First Quarter 2008 Results Conference Call and Web Cast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... November 28, 2014 Recently, DressVe , ... 2014 Cyber Monday Sales, which are valid during Nov. 29 ... are available on these new dresses, up to 90% off. ... $69. Click to view more at http://www.dressve.com/ , ... really a great way to showcase somebody’s personality and figure. ...
(Date:11/27/2014)... 28, 2014 This is a professional ... global Bronchoscopes industry with a focus on the Chinese ... status of the Bronchoscopes manufacturers and is a valuable ... interested in the industry. , Firstly, the report provides ... applications and manufacturing technology. Then, the report explores the ...
(Date:11/27/2014)... November 28, 2014 The American Society for ... social media campaign in honor of World AIDS Day 2014. ... tested. Find a cure.” icon and infographic designed to generate ... getting tested for HIV. , ASCP has asked members to ... “Give a minute. Get Tested. Find a cure.” icon and ...
(Date:11/27/2014)... Vancouver, BC (PRWEB) November 27, 2014 ... http://www.idataresearch.com ), those companies looking to break into the ... in other medical specialties, other than the MIS field ... almost one-third of the U.S. surgical robotics market by ... nearing saturation,” explains Dr. Kamran Zamanian, CEO and President ...
(Date:11/27/2014)... 2014 In a world enveloped ... sleep has lessened, and due to the intrusion ... of sleep has eroded. According to Web MD, ... job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high ... an incalculable amount, leading not only to dissatisfied ...
Breaking Medicine News(10 mins):Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... SMA, the leading ... toddler mortality, BETHESDA, Md., Sept. 28 With the ... Representatives and the U.S.,Senate to create a national clinical trials ... hosting a two-day,summit to work toward reducing or eliminating barriers ...
... proactive in diagnosing the condition, study says , , FRIDAY, Sept. ... depression before, during or after pregnancy, a new study finds. ... mother, her baby and her entire family, according to the ... Journal of Psychiatry . , "The prevalence of women diagnosed ...
... Bradley,Pharmaceuticals, Inc. (NYSE: BDY ) today announced ... gel 0.06%) at,the 18th Annual North American Menopause ... Texas from October 3-6, 2007. Elestrin(TM) is ... prescription, for the treatment of moderate-to-severe,vasomotor symptoms associated ...
... and,famous Chicago chefs watching their every move, the competition ... Battle of the Hospital,Chefs. Chef William Read, however, ... patients at Saint Mary,s Health Care in Grand Rapids, ... the reigning champion of,chefs among the nearly 550 Consorta ...
... (NSF) is a newly identified debilitating and painful condition ... by a thickening and hardening of the skin. It ... also affect internal organs and can progress so rapidly ... few weeks. Although it is not clear what causes ...
... family support and problems in ones neighborhood are associated ... to researchers in Vancouver, Canada. , Social environment has ... asthma manifestations in youth, but few studies have empirically ... levels and their implications for childhood asthma. , Edith ...
Cached Medicine News:Health News:15% of Women Struggle With Pregnancy-Related Depression 2Health News:15% of Women Struggle With Pregnancy-Related Depression 3Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 2Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 3Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 4Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 5Health News:National Battle of the Hospital Chefs Cooks Up a Winner 2Health News:Higher death rates in kidney patients with newly recognized disease 2Health News:Higher death rates in kidney patients with newly recognized disease 3Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3
(Date:11/26/2014)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... research report by IQ4I Research and Consultancy focusing on ... learn more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 ... Active Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... CHARLOTTE, N.C. , Nov. 25, 2014  At ... San Antonio this October, KaVo Kerr Group ... Institute Technology Expo, offering attendees the opportunity to see ... to well-respected key opinion leaders deliver lectures on the ... Kerr Group products include the new DEXIS CariVu Caries ...
(Date:11/26/2014)... 2014 Reinforcing its commitment to enabling confident ... PHG AEX: PHIA) today announced 510(k) clearance ... its IQon Spectral CT , presenting an entirely ... adds a new dimension to Computed Tomography (CT) imaging, ... structures based on their material content within a single ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... (Nasdaq: CEPH ) today announced that the ... U.S. Food and Drug Administration (FDA) for the supplemental ... for the treatment of patients with excessive sleepiness associated ... its letter to the company, the FDA reiterated its ...
... (Nasdaq: DRRX ) today reported that King Pharmaceuticals, ... (Nasdaq: PTIE ) have announced that King has ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 2Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 3REMOXY® New Drug Application Resubmitted 2REMOXY® New Drug Application Resubmitted 3
One step Immuno-Chromatographic Assay for the detection of C. difficile toxin A....
... If the optical viewing aids should not ... Almost every household has a television set today. ... images can be enlarged up to 70 times. ... the reading material on the television monitor. The ...
... better resolution, accuracy and easy operation TOMEYs ... rings (same as TMS-1), providing high resolution. ... & repeatability. The small cone design eliminates ... corneal coverage. The low light level of ...
... Pachymeter SP-3000 covers all needs regarding pachymetry ... health care., ,Compact design, colored touch-screen and ... be an "easy-to-use unit.,The wide measurement range ... you the possibility to measure very thin ...
Medicine Products: